Computational design of protein binders that boost the antitumour efficacy of CAR T cells

被引:0
|
作者
Xia, Zhen [1 ]
Xie, Qi [1 ]
机构
[1] Westlake Univ, Hangzhou, Peoples R China
来源
NATURE BIOMEDICAL ENGINEERING | 2024年 / 8卷 / 12期
关键词
HETEROGENEITY; REVEALS;
D O I
10.1038/s41551-024-01263-x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
We computationally designed protein binders for chimeric antigen receptor (CAR) constructs to target the glioblastoma-associated antigens EGFR and CD276. Compared with standard CAR T cells, CAR T cells with the de novo-designed binders showed enhanced proliferation, cytokine release and resistance to exhaustion, as well as superior antitumour effects in vitro and in vivo.
引用
收藏
页码:1521 / 1522
页数:2
相关论文
共 50 条
  • [31] CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers
    Chuan Jin
    Jing Ma
    Mohanraj Ramachandran
    Di Yu
    Magnus Essand
    Nature Biomedical Engineering, 2022, 6 : 830 - 841
  • [32] CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers
    Jin, Chuan
    Ma, Jing
    Ramachandran, Mohanraj
    Yu, Di
    Essand, Magnus
    NATURE BIOMEDICAL ENGINEERING, 2022, 6 (07) : 830 - 841
  • [33] Stabilization of long CAR T cells is crucial for in vivo antitumor efficacy
    Paavilainen, Henrik
    Koski, Jan
    Nikoskelainen, Veera
    Elmadani, Manar
    Elbasani, Endrit
    Hekim, Can
    Ihantola, Emmi-Leena
    Kergourlay, Virginie
    Vehmaan-Kreula, Pirjo
    Nyman, Marie
    Kalke, Kiira
    Nurmi, Markus
    Monzo, Hector
    Ojala, Paivi
    Autio, Anu
    Korhonen, Matti
    Thotakura, Anil
    CANCER RESEARCH, 2024, 84 (06)
  • [34] Design of CAR T cells targeting metastatic colorectal cancer
    Marino, I.
    Guidi, F.
    Lanza, P.
    Paglialunga, M.
    Lucchisani, S.
    Ponterio, E.
    Haas, T.
    De Maria, R.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A207 - A208
  • [35] Enhancing the Efficacy of CAR T Cells in the Tumor Microenvironment of Pancreatic Cancer
    Henze, Janina
    Tacke, Frank
    Hardt, Olaf
    Alves, Frauke
    Al Rawashdeh, Wa'el
    CANCERS, 2020, 12 (06)
  • [36] Optimizing efficacy and security of CAR-T cells, and immune monitoring
    Lew-Derivry, Lucille
    Lamrani, Lamia
    Alcantara, Marion
    Alanio, Cecile
    M S-MEDECINE SCIENCES, 2024, 40 (05): : 445 - 453
  • [37] Targeting metabolism to improve CAR-T cells therapeutic efficacy
    Liu, Shasha
    Zhao, Yuyu
    Gao, Yaoxin
    Li, Feng
    Zhang, Yi
    CHINESE MEDICAL JOURNAL, 2024, 137 (08) : 909 - 920
  • [38] Development of CAR T cells designed to improve antitumor efficacy and safety
    Jaspers, Janneke E.
    Brentjens, Renier J.
    PHARMACOLOGY & THERAPEUTICS, 2017, 178 : 83 - 91
  • [39] Intermittent rest of CAR-T cells improves their therapeutic efficacy
    Sroussi, Marine
    Rosado, Edith
    M S-MEDECINE SCIENCES, 2022, 38 (04): : 348 - 350
  • [40] Targeting metabolism to improve CAR-T cells therapeutic efficacy
    Liu Shasha
    Zhao Yuyu
    Gao Yaoxin
    Li Feng
    Zhang Yi
    中华医学杂志英文版, 2024, 137 (08)